# Redox cycling nitroxide limits cellular iron availability and selectively inhibits iron-sulfur cluster metabolism

## TL;DR

A redox cycling compound called Tempol limits iron availability in cells, affecting iron-sulfur cluster metabolism and cell survival.

## Contribution

Tempol's unique mechanism of iron limitation and its effects on iron-sulfur cluster metabolism are newly characterized.

## Key findings

- Tempol limits iron bioavailability through ascorbate and iron redox balance.
- Tempol disrupts iron-sulfur cluster synthesis in some cell lines, reducing cell viability.
- Ascorbate reverses Tempol's effects and inhibits ferroptosis.

## Abstract

Iron-sulfur clusters (ISCs) are redox active cofactors for essential proteins with diverse functions. We demonstrate that Tempol, a redox cycling nitroxide, limits iron bioavailability in a manner distinct from iron chelators, mainly via its effect on ascorbate and iron redox balance. This non-canonical iron limitation triggers upregulation of IRP2 and HIF1α, proteins whose degradation is ferrous iron-dependent, while disrupting ISC synthesis only in a subset of cell lines. Suppression of ISC synthesis inhibits ISC-dependent enzymes, destabilizes ISC proteins, and reduces cell viability, particularly in cells dependent on ISC protein ACO2. These effects are reversed by the reducing agent ascorbate, a cofactor required for multiple enzymes, such as the HIF1α prolyl hydroxylases. Tempol treatment also inhibits ferroptosis, an oxidative form of cell death catalyzed by reduced iron. These results demonstrate ascorbate and cellular iron redox state are essential in iron homeostasis, which is proposed to underlie pathological conditions from neurodegeneration to cancer.